BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35902192)

  • 1. Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015-2020.
    Jeyashree K; Thangaraj J; Rade K; Modi B; Selvaraju S; Velusamy S; Akhil S; Vijayageetha M; Sudha Rani D; Sabarinathan R; Manikandanesan S; Elumalai R; Natarajan M; Joseph B; Mahapatra A; Shamim A; Shah A; Bhardwaj A; Purty A; Vadera B; Sridhar A; Chowdhury A; Shafie A; Choudhury A; Dhrubjyoti D; Solanki H; Sirmanwar K; Khaparde K; Parmar M; Dahiya N; Debdutta P; Ahmed Q; Ramachandran R; Prasad R; Shinde R; Baruah R; Chauhan S; Bharaswadkar S; Achanta S; Sharath BN; Balakrishnan S; Chandra S; Khumukcham S; Mandal S; Chalil S; Shah V; Roddawar V; Rao R; Sachdeva K; Murhekar M;
    BMJ Open; 2022 Jul; 12(7):e060197. PubMed ID: 35902192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.
    Lee DJ; Kumarasamy N; Resch SC; Sivaramakrishnan GN; Mayer KH; Tripathy S; Paltiel AD; Freedberg KA; Reddy KP
    PLoS One; 2019; 14(7):e0218890. PubMed ID: 31265470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upfront Xpert MTB/RIF for diagnosis of pediatric TB-Does it work? Experience from India.
    Kalra A; Parija D; Raizada N; Sachdeva KS; Rao R; Swaminathan S; Khanna A; Chopra KK; Hanif M; Singh V; Umadevi KR; Sheladia KN; Rao R; Vasundhara N; S A; A R N; Azeem A; Chhajlani V; Khurana J; Das NJ; Choudhury B; Nair SA; Mall S; Sen R; Chadha SS; Denkinger CM; Boehme C; Sarin S
    PLoS One; 2020; 15(8):e0236057. PubMed ID: 32756559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating TB diagnostic costs incurred under the National Tuberculosis Elimination Programme: a costing study from Tamil Nadu, South India.
    Muniyandi M; Lavanya J; Karikalan N; Saravanan B; Senthil S; Selvaraju S; Mondal R
    Int Health; 2021 Dec; 13(6):536-544. PubMed ID: 33570132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients.
    Gomathi NS; Singh M; Myneedu VP; Chauhan DS; Tripathy S; Sarin R; Mohan A; Bhatnagar A; Khangembam JS; Kannan T; V Rao MV; Logani J; Dey B; Gangakhedkar RR; Swaminathan S; Singh UB
    Indian J Med Res; 2020 Nov; 152(5):482-489. PubMed ID: 33707390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalance of tuberculosis amongst healthcare workers, working in DOTS/sputum microscopy centre in two different districts of state of Uttarakhand & Uttar Pradesh of India.
    Ahmad P; Arora VK
    Indian J Tuberc; 2023 Oct; 70(4):405-408. PubMed ID: 37968045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Advocacy, Communication, Social Mobilization and Active Case Finding on TB Notification in Jharkhand, India.
    Shewade HD; Gupta V; Ghule VH; Nayak S; Satyanarayana S; Dayal R; Mohanty S; Singh S; Biswas M; Reddy KK; Mallick G; Bera OP; Pandey P; Pandurangan S; Rao R; Prasad BM; Kumar AMV; Chadha SS
    J Epidemiol Glob Health; 2019 Dec; 9(4):233-242. PubMed ID: 31854164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerating TB notification from the private health sector in Delhi, India.
    Kundu D; Chopra K; Khanna A; Babbar N; Padmini TJ
    Indian J Tuberc; 2016 Jan; 63(1):8-12. PubMed ID: 27235938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in incidence and mortality of tuberculosis in India over past three decades: a joinpoint and age-period-cohort analysis.
    Dhamnetiya D; Patel P; Jha RP; Shri N; Singh M; Bhattacharyya K
    BMC Pulm Med; 2021 Nov; 21(1):375. PubMed ID: 34784911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India.
    Dravid A; Natarajan K; Medisetty M; Gawali R; Mahajan U; Kulkarni M; Saraf C; Ghanekar C; Kore S; Rathod N; Dravid M
    BMC Infect Dis; 2019 Aug; 19(1):714. PubMed ID: 31409289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A TB model: Is disease eradication possible in India?
    Pandey S; Venturino E
    Math Biosci Eng; 2018 Feb; 15(1):233-254. PubMed ID: 29161834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating tuberculosis burden and case detection in Pakistan.
    Fatima R; Harris RJ; Enarson DA; Hinderaker SG; Qadeer E; Ali K; Bassili A
    Int J Tuberc Lung Dis; 2014 Jan; 18(1):55-60. PubMed ID: 24365553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of rifampin-resistant tuberculosis in mountainous districts of India.
    Dorjee K; Sadutshang TD; Rana RS; Topgyal S; Phunkyi D; Choetso T; Chodon T; Parmar M; Singla R; Paster Z; Chaisson RE; Kaushal KC
    Indian J Tuberc; 2020 Jan; 67(1):59-64. PubMed ID: 32192619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
    Sachdeva KS; Raizada N; Sreenivas A; Van't Hoog AH; van den Hof S; Dewan PK; Thakur R; Gupta RS; Kulsange S; Vadera B; Babre A; Gray C; Parmar M; Ghedia M; Ramachandran R; Alavadi U; Arinaminpathy N; Denkinger C; Boehme C; Paramasivan CN
    PLoS One; 2015; 10(5):e0126065. PubMed ID: 25996389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TB notification rates across parliamentary constituencies in India: a step towards data-driven political engagement.
    Pardeshi G; Wang W; Kim J; Blossom J; Kim R; Subramanian SV
    Trop Med Int Health; 2021 Jul; 26(7):730-742. PubMed ID: 33715264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends and sub-national disparities in TB notifications in India: Insights from HMIS data.
    Golandaj JA; Naikar SK; Hallad JS
    Indian J Tuberc; 2022 Apr; 69(2):141-150. PubMed ID: 35379393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Xpert MTB/RIF for TB diagnosis in the private sector: evidence from large-scale pilots in Patna and Mumbai, India.
    Deo S; Jindal P; Papineni S
    BMC Infect Dis; 2021 Jan; 21(1):123. PubMed ID: 33509114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of Private Drugs' Sales and Costs Incurred by Patients on Anti-tuberculosis Drugs in Selected Districts of Jharkhand (2022): Results From Sub-national TB-Free Certification.
    Sinha R; Rana RK; Kujur A; Jahnavi G; Kumar M; Venugopal V; Priya N; Kujur M; Jha RR; Barnwal R; Nishant N; Murmu N; Pathak R; T A; Prasad R; Dayal R; Modi B; Purty AJ; Bn S; Nair D; Kumar D
    Cureus; 2023 Oct; 15(10):e47296. PubMed ID: 38021489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
    Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
    Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trend in the incidence of smear-positive tuberculosis in a district in South India after DOTS implementation.
    Subramani R; Gomathy S; Lakshmi M; Swaminathan S
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1022-6. PubMed ID: 27393534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.